These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 8188084

  • 21. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC, Keiser JA.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [Abstract] [Full Text] [Related]

  • 22. Effects of phorbol dibutyrate on cell proliferation, apoptosis, and tumor necrosis factor-alpha expression in human endometrial adenocarcinoma cells.
    Wieser F, Vigne JL, Wenzl R, Huber J, Taylor RN.
    J Soc Gynecol Investig; 2005 Jul; 12(5):370-5. PubMed ID: 15979550
    [Abstract] [Full Text] [Related]

  • 23. Epidermal growth factor stimulation of phosphatidylinositol 3-kinase during wound closure in rabbit corneal epithelial cells.
    Zhang Y, Akhtar RA.
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1139-48. PubMed ID: 9152233
    [Abstract] [Full Text] [Related]

  • 24. Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells.
    Kargman S, Ali A, Vaillancourt JP, Evans JF, Nicholson DW.
    Mol Pharmacol; 1994 May; 45(5):1043-9. PubMed ID: 8190095
    [Abstract] [Full Text] [Related]

  • 25. Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells.
    Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Mazzotta A, Manca C, Marsigliante S.
    J Cell Physiol; 2003 Aug; 196(2):370-7. PubMed ID: 12811831
    [Abstract] [Full Text] [Related]

  • 26. Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cells.
    Sako T, Tauber AI, Jeng AY, Yuspa SH, Blumberg PM.
    Cancer Res; 1988 Aug 15; 48(16):4646-50. PubMed ID: 2899457
    [Abstract] [Full Text] [Related]

  • 27. The epidermal growth factor receptor in the human endometrial adenocarcinoma cell line HEC-1-B.
    Watson H, Franks S, Bonney RC.
    J Steroid Biochem Mol Biol; 1994 Oct 15; 51(1-2):41-5. PubMed ID: 7947349
    [Abstract] [Full Text] [Related]

  • 28. Characterization of epidermal growth factor (EGF) receptor and biological effect of EGF on human uterine cervical adenocarcinoma cell line OMC-4.
    Ueda M, Ueki M, Sugimoto O.
    Hum Cell; 1993 Sep 15; 6(3):218-25. PubMed ID: 8297819
    [Abstract] [Full Text] [Related]

  • 29. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.
    Akinaga S, Gomi K, Morimoto M, Tamaoki T, Okabe M.
    Cancer Res; 1991 Sep 15; 51(18):4888-92. PubMed ID: 1893379
    [Abstract] [Full Text] [Related]

  • 30. Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways.
    Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT.
    J Neurosurg; 1990 Jul 15; 73(1):98-105. PubMed ID: 2161913
    [Abstract] [Full Text] [Related]

  • 31. The antiproliferative effects of staurosporine are not exclusively mediated by inhibition of protein kinase C.
    Smith CD, Glickman JF, Chang KJ.
    Biochem Biophys Res Commun; 1988 Nov 15; 156(3):1250-6. PubMed ID: 3190703
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of stimulus-dependent epidermal growth factor receptor and transforming growth factor-alpha mRNA accumulation by the protein kinase C inhibitor staurosporine.
    Bjorge JD, Kudlow JE, Mills GB, Paterson AJ.
    FEBS Lett; 1989 Jan 30; 243(2):404-8. PubMed ID: 2465187
    [Abstract] [Full Text] [Related]

  • 33. Tumor promoter-dependent mouse leukemia cell line.
    Kaneshima H, Hiai H, Fujiki H, Oguro YB, Iijima S, Sugimura T, Nishizuka Y.
    Cancer Res; 1983 Oct 30; 43(10):4676-80. PubMed ID: 6883326
    [Abstract] [Full Text] [Related]

  • 34. Increase in postirradiation survival of rat 3Y1 fibroblasts by a protein kinase inhibitor, staurosporine.
    Nakamura K, Antoku S.
    Cancer Biochem Biophys; 1994 Apr 30; 14(1):15-21. PubMed ID: 7796385
    [Abstract] [Full Text] [Related]

  • 35. Protein kinase C and adenylate cyclase as targets for growth inhibition of human gastric cancer cells.
    Piontek M, Hengels KJ, Porschen R, Strohmeyer G.
    J Cancer Res Clin Oncol; 1993 Apr 30; 119(12):697-9. PubMed ID: 8408180
    [Abstract] [Full Text] [Related]

  • 36. Involvement of protein kinase C in growth regulation of human meningioma cells.
    Todo T, Fahlbusch R.
    Acta Neurochir (Wien); 1994 Apr 30; 131(3-4):282-8. PubMed ID: 7754836
    [Abstract] [Full Text] [Related]

  • 37. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro.
    Couldwell WT, Uhm JH, Antel JP, Yong VW.
    Neurosurgery; 1991 Dec 30; 29(6):880-6; discussion 886-7. PubMed ID: 1758601
    [Abstract] [Full Text] [Related]

  • 38. Epidermal growth factor receptor expression in three different human endometrial cancer cell lines.
    Lelle RJ, Talavera F, Gretz H, Roberts JA, Menon KM.
    Cancer; 1993 Jul 15; 72(2):519-25. PubMed ID: 8319182
    [Abstract] [Full Text] [Related]

  • 39. Neurotrophic effects of epidermal growth factor on cultured brain neurons are blocked by protein kinase inhibitors.
    Abe K, Takayanagi M, Saito H.
    Jpn J Pharmacol; 1992 Jun 15; 59(2):259-61. PubMed ID: 1434124
    [Abstract] [Full Text] [Related]

  • 40. Induction of apoptosis in MDA-231 cells by protein synthesis inhibitors is suppressed by multiple agents.
    Geier A, Bar-Shalom I, Beery R, Haimsohn M, Hemi R, Malik Z, Lunenfeld B, Karasik A.
    Cancer Invest; 1996 Jun 15; 14(5):435-44. PubMed ID: 8816859
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.